The Fanconi anaemia/BRCA pathway

Cited by (823)

Items 401–500 of 823

1. The Fanconi Family Adds a Fraternal Twin
   Markus Grompe, Henri van de Vrugt · 2007 · Developmental Cell
2. Nematode modulation of inflammatory bowel disease
   Rose Whelan, Susanne Hartmann, Sebastian Rausch · 2011 · PROTOPLASMA
3. Finding the needle in the hay stack: Hematopoietic stem cells in Fanconi anemia
   Lars Müller, David A. Williams · 2009 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
4. Overlooked FANCD2 variant encodes a promising, portent tumor suppressor, and alternative polyadenylation contributes to its expression
   Bing Han, Yihang Shen, Piyan Zhang, Jayabal Panneerselvam, Raymond Che, Jun Zhang, Herbert Yu, Peiwen Fei · 2017 · Oncotarget
5. Molecular Biology of Oral Cavity Squamous Cell Carcinoma
   Michael Elliot Kupferman, Jeffrey N. Myers · 2006 · Otolaryngologic Clinics of North America
6. A new nuclease member of the FAN club
   Huang, Min, D'Andrea, Alan D · 2010 · Nature Structural & Molecular Biology
7. Co-opting the Fanconi Anemia Genomic Stability Pathway Enables Herpesvirus DNA Synthesis and Productive Growth
   Heidi Karttunen, Jeffrey N. Savas, Caleb C. McKinney, Yu-Hung Chen, John R. Yates, Veijo Hukkanen, Tony T. Huang, Ian Mohr · 2014 · Molecular Cell
8. A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays
   Kajal Biswas, Gary B. Lipton, Stacey Stauffer, Teresa L. Sullivan, Linda Cleveland, Eileen A. Southon, Susan W. Reid, Valentin Magidson, Edwin S. Iversen, Shyam K. Sharan · 2020 · npj Genomic Medicine
9. Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
   Dmitri Pchejetski, Albandri Alfraidi, Keith A. Sacco, Heba A Alshaker, Aun Muhammad, Leonardo Monzon · 2015 · Journal of Cancer Research and Clinical Oncology
10. Lower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair
    Katrin Arnold, Minkyoung Kim, Katrin Frerk, Lutz Edler, Larissa Savelyeva, Peter Schmezer, Ruprecht Wiedemeyer · 2006 · Cancer Letters
11. Telomere dynamics in Fancg-deficient mouse and human cells
    Sonia Franco, Henri J. van de Vrugt, Piedad Fernández, Miguel Aracil, Fré Arwert, Marı́a A. Blasco · 2004 · Blood
12. Human Mus81 and FANCB independently contribute to repair of DNA damage during replication
    Yuji Nomura, Noritaka Adachi, Hideki Koyama · 2007 · Genes to Cells
13. UBE2W Interacts with FANCL and Regulates the Monoubiquitination of Fanconi Anemia Protein FANCD2
    Yingying Zhang, Xiaowei Zhou, Lixia Zhao, Chao Li, Heng-Qi Zhu, Long Xu, Liran Shan, Xiang Liao, Zekun Guo, Peitang Huang · 2011 · Molecules and Cells
14. Rad18 is required for functional interactions between FANCD2, BRCA2, and Rad51 to repair DNA topoisomerase 1-poisons induced lesions and promote fork recovery
    Kaushlendra K. Tripathi, Chinnadurai Mani, David W Clark, Komaraiah Palle · 2016 · Oncotarget
15. Evaluation of the methods to identify patients who may benefit from PARP inhibitor use
    Diana Gkeok Stzuan Lim, Joanne Yuen Yie Ngeow · 2016 · Endocrine Related Cancer
16. Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine
    Chiara Varamo, Caterina Peraldo Neia, Paola Ostano, Marco Basiricò, Chiara Raggi, Paola Bernabei, Tiziana Venesio, Enrico Berrino, Massimo Aglietta, Francesco Leone et al. · 2019 · Cancers
17. Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension
    Sarasa Isobe, Ramesh V. Nair, Helen Y. Kang, Lingli Wang, Jan-Renier A. J. Moonen, Tsutomu Shinohara, Aiqin Cao, Shalina Taylor, Shoichiro Otsuki, David P. Marciano et al. · 2023 · Nature Communications
18. Genome Stability Pathways in Head and Neck Cancers
    Glenn Jenkins, Kenneth John O'Byrne, Benedict James Panizza, Derek J. Richard · 2013 · International Journal of Genomics
19. Cell cycle inhibitor, p19INK4d, promotes cell survival and decreases chromosomal aberrations after genotoxic insult due to enhanced DNA repair
    María Élida Scassa, Mariela Claudia Marazita, Julieta María Ceruti, Abel L. Carcagno, Pablo F. Sirkin, Marcela González‐Cid, Omar P. Pignataro, Eduardo Tomás Cánepa · 2007 · DNA repair
20. Systems-level analysis of risk genes reveals the modular nature of schizophrenia
    Jiewei Liu, Ming Li, Xiong‐Jian Luo, Bing Su · 2018 · Schizophrenia Research
21. Secular Trends in Outcomes for Fanconi Anemia Patients Who Receive Transplants: Implications for Future Studies
    Philip S. Rosenberg, Blanche P. Alter, Gèrard Socié, Éliane Gluckman · 2005 · Transplantation and Cellular Therapy
22. A cross‐linker‐sensitive myeloid leukemia cell line from a 2‐year‐old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations
    Stefan Meyer, William D. Fergusson, Anneke B. Oostra, Annette L. Medhurst, Quinten Waisfisz, Johan P. de Winter, Fei Chen, Trevor F. Carr, Jill Clayton‐Smith, Tara Clancy et al. · 2005 · Genes Chromosomes and Cancer
23. ZNF365 Promotes Stability of Fragile Sites and Telomeres
    Yuqing Zhang, Sandra Jean Shin, Debra Liu, Elena V. Ivanova, Friedrich Foerster, Haoqiang Ying, Hongwu Zheng, Yonghong Xiao, Zhengming Chen, Alexei I. Protopopov et al. · 2013 · Cancer Discovery
24. Basic and Preclinical Research for Personalized Medicine
    Wanda Lattanzi, Cristian Ripoli, Viviana Greco, Marta Barba, Federica Iavarone, Angelo Minucci, Andrea Urbani, Claudio Grassi, Ornella Parolini · 2021 · Journal of Personalized Medicine
25. Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism
    Ilaria Gritti, Veronica Basso, Darawan Rinchai, Federica Corigliano, Silvia Pivetti, Marco Gaviraghi, Dalia Rosano, Davide Mazza, Sara Barozzi, Marco Roncador et al. · 2022 · The EMBO Journal
26. BRCA1: A Missing Link in the Fanconi Anemia/BRCA Pathway
    Alan D. D’Andrea · 2013 · Cancer Discovery
27. Genetic changes and DNA damage responses in the prostate
    Taija af Hällström, Marikki Laiho · 2008 · The Prostate
28. Loss of Ubr2, an E3 ubiquitin ligase, leads to chromosome fragility and impaired homologous recombinational repair
    Yan Ouyang, Yong Tae Kwon, Jee Young An, Danny Eller, Shih-Chang Tsai, Silvia V. Diaz-Perez, Joshua J. Troke, Michael A. Teitell, York Marahrens · 2006 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
29. Multifunctional nanoparticles for targeting cancer and inflammatory diseases
    Shardool Jain, Aatman S. Doshi, Arun K. Iyer, Mansoor M. Amiji · 2013 · Journal of drug targeting
30. Fanconi Anemia and Ubiquitination
    Yingying Zhang, Xiaowei Zhou, Peitang Huang · 2007 · Journal of genetics and genomics/Journal of Genetics and Genomics
31. FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer
    Jayabal Panneerselvam, Hwan Ki Park, Jun Zhang, Fred Duafalia Dudimah, Piyan Zhang, Hong Wang, Peiwen Fei · 2012 · Cell Cycle
32. Ethical considerations in genomic testing for hematologic disorders
    Jonathan Michael Marron, Steven Joffe · 2017 · Blood
33. Involvement of FANCD2 in Energy Metabolism via ATP5α
    Jayabal Panneerselvam, Chi Ma, Manoj K. Nepal, Yihang Shen, Raymond Che, James Turkson, Peiwen Fei · 2017 · Scientific Reports
34. The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC
    France Léveillé, Miriam Ferrer, Annette L. Medhurst, El Houari Laghmani, Martin A. Rooimans, Patrick Bier, Jûrgen Steltenpool, Tom A. Titus, John H. Postlethwait, Maureen E. Hoatlin et al. · 2006 · DNA repair
35. Syndromes Predisposing to Pediatric Central Nervous System Tumors: Lessons Learned and New Promises
    Anita Villani, David M. Malkin, Uri Y. Tabori · 2011 · Current Neurology and Neuroscience Reports
36. Fanconi anemia proteins in telomere maintenance
    Jaya Sarkar, Yie Liu · 2016 · DNA repair
37. Understanding DNA Damage Response and DNA Repair in Multiple Myeloma
    Cole Petrilla, Joshua Galloway, Ruchi Kudalkar, Aya Ismael, Francesca Cottini · 2023 · Cancers
38. Genomic Instability in Chronic Myeloid Leukemia: Targets for Therapy?
    Nidal E. Muvarak, Pratik K. Nagaria, Feyruz Virgilia Rassool · 2012 · Current Hematologic Malignancy Reports
39. Selection and the Cell Cycle: Positive Darwinian Selection in a Well-Known DNA Damage Response Pathway
    Mary J. O’Connell · 2010 · Journal of Molecular Evolution
40. Mammalian SNM1 is required for genome stability
    Aaron Hemphill, Donald A. Bruun, Lori A. Thrun, Yassmine M. N. Akkari, Yumi Torimaru, K. Hejna, Petra M. Jakobs, James Hejna, Steven J.M. Jones, Susan B. Olson et al. · 2008 · Molecular Genetics and Metabolism
41. 3R coordination by Fanconi anemia proteins
    Gaëtane Macé‐Aimé, Massimo Bogliolo, Jean-Hugues Guervilly, Jean-Antoine Dugas du Villard, Filippo Rosselli · 2005 · Biochimie
42. MERIT40 cooperates with BRCA2 to resolve DNA interstrand cross-links
    Qinqin Jiang, Manikandan Paramasivam, Bernadette Aressy, Junmin Wu, Marina A. Bellani, Wei Tong, Michael M. Seidman, Roger A. Greenberg · 2015 · Genes & Development
43. A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer
    Ke Ding, Youhua He, Jinfen Wei, Shuying Fu, Jiajian Wang, Zixi Chen, Haibo Zhang, Yimo Qu, Keying Liang, Xiaocheng Gong et al. · 2022 · Frontiers in Immunology
44. K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks
    Bin Zhu, Kaowen Yan, Li Li, Menghan Lin, Sufang Zhang, Qiguang He, Duo Zheng, Hua Yang, Genze Shao · 2014 · Oncogene
45. The involvement of FANCM, FANCI, and checkpoint proteins in the interstrand DNA crosslink repair pathway is conserved in C. elegans
    Kyong Yun Lee, Kee Yang Chung, Hyeon‐Sook Koo · 2010 · DNA repair
46. Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents
    Wenrui Duan, Li Gao, Weiqiang Zhao, Marino E. Leon, Wolfgang Sadée, Amy Webb, Kimberly Erin Resnick, Xin Wu, Bhuvaneswari Ramaswamy, David E. Cohn et al. · 2012 · Translational research
47. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low‐dose busulfan and cyclophosphamide as conditioning
    Lamia Torjemane, Saloua Ladeb, Tarek Ben Othman, A Abdelkefi, Amel Lakhal, A Ben Abdeladhim · 2005 · Pediatric Blood & Cancer
48. FANCD2 mRNA Overexpression is a Bona Fide Indicator of Lymph Node Metastasis in Human Colorectal Cancer
    Heita Ozawa, Masaaki Iwatsuki, Koshi Mimori, Tetsuya Sato, Fredrik Johansson, Hiroyuki Toh, Masahiko Watanabe, Masaki Mori · 2010 · Annals of Surgical Oncology
49. Influence of microglia on retinal progenitor cell turnover and cell replacement
    Andrew D. Dick · 2008 · Eye
50. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems
    Yasufumi Kaneda · 2008 · Expert Opinion on Drug Delivery
51. Bone Marrow Failure: A Child Is Not Just a Small Adult (But an Adult Can Have a Childhood Disease)
    Blanche P. Alter · 2005 · Hematology
52. Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs
    Hannah Tamary, Orly Dgany, Helen Toledano, Zvi Shalev, Tatyana Krasnov, Lea Shalmon, Tali Schechter, Dani Bercovich, Dina Attias, Ruth Laor et al. · 2004 · European Journal Of Haematology
53. Repeated Sequences in CASPASE-5 and FANCD2 but not NF1 Are Targets for Mutation in Microsatellite-Unstable Acute Leukemia/Myelodysplastic Syndrome
    Judith Offman, Karen E. Gascoigne, Fiona Bristow, Peter Macpherson, Margherita Bignami, Ida Casorelli, Giuseppe G.M. Leone, Livio Pagano, Simona Sica, Ozay Halil et al. · 2005 · Molecular Cancer Research
54. Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis
    John M. Hinz, Peter B. Nham, Salustra S. Urbin, Irene M. Jones, Larry H. Thompson · 2007 · Nucleic Acids Research
55. DNA Repair: Exploiting the Fanconi Anemia Pathway As a Potential Therapeutic Target
    Tomáš Hucl, Eike Gallmeier · 2011 · Physiological Research
56. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei
    Flavia Zita Francies, Rosalind Wainwright, Janet Poole, Kim De Leeneer, Ilse Coene, Greet Wieme, Hélène Antoine Poirel, Bénédicte Brichard, Stephanie Vermeulen, Anne Vral et al. · 2017 · DNA repair
57. SARS-CoV-2 and the DNA damage response
    Roger J.A. Grand · 2023 · Journal of General Virology
58. BRCA /Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer
    Shinsuke Nakashima, Shogo Kobayashi, Hiroaki Nagano, Akira Tomokuni, Yoshito Tomimaru, Tadafumi Asaoka, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, Shigeru Marubashi et al. · 2015 · Cancer Science
59. A modified thymine for the synthesis of site-specific thymine-guanine DNA interstrand crosslinks
    Jawad Alzeer, Orlando D. Schärer · 2006 · Nucleic Acids Research
60. Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair
    Miguel Angel Villalona-Calero, Wenrui Duan, Weiqiang Zhao, Konstantin Shilo, Larry J. Schaaf, Jennifer Thurmond, Judith A. Westman, John Lindsay Marshall, Xiaobai Li, Jiuping Jay Ji et al. · 2016 · JNCI Journal of the National Cancer Institute
61. Regulation of various DNA repair pathways by E3 ubiquitin ligases
    Chandramouli Natarajan, Ken’ichi Takeda · 2017 · Journal of Cancer Research and Therapeutics
62. Disease classification via gene network integrating modules and pathways
    Zhilong Mi, Binghui Guo, Ziqiao Yin, Jiahui Li, Zhiming Zheng · 2019 · Royal Society Open Science
63. Loss of GGN Leads to Pre-Implantation Embryonic Lethality and Compromised Male Meiotic DNA Double Strand Break Repair in the Mouse
    Duangporn Jamsai, Anne E. O’Connor, Kathleen DeBoer, Brett J. Clark, Stephanie J. Smith, Catherine M. Browne, Jonathan G. Bensley, Julie A. Merriman, Wai Shan Yuen, Peter A. Koopman et al. · 2013 · PLoS ONE
64. Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage
    Pau Castillo Bosch, Massimo Bogliolo, Jordi Surrallés · 2011 · DNA repair
65. Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma
    Hisateru Komatsu, Takaaki Masuda, Tomohiro Iguchi, Sho Nambara, Kuniaki Sato, Qingjiang Hu, Hidenari Hirata, Shuhei Ito, Hidetoshi Eguchi, Keishi Sugimachi et al. · 2017 · Anticancer Research
66. Loss of homologous recombination or non-homologous end-joining leads to radial formation following DNA interstrand crosslink damage
    Amy E. Hanlon Newell, Aaron Hemphill, Yassmine M. N. Akkari, James Hejna, R E Moses, Susan B. Olson · 2008 · Cytogenetic and Genome Research
67. A role for PKR in hematologic malignancies
    William L. Blalock, Alberto Bavelloni, Manuela Piazzi, Irene Faenza, Lucio Cocco · 2010 · Journal of Cellular Physiology
68. Frequency of Fanconi anemia in Brazil and efficacy of screening for the FANCA 3788-3790del mutation
    Neiva Magdalena, Daniela Pilonetto, Marco Antonio Bitencourt, Noemi Farah Pereira, Raul Correa Ribeiro, Michael Jeng, Ricardo Pasqüini · 2005 · Brazilian Journal of Medical and Biological Research
69. Brca2 deficiency in the murine small intestine sensitizes to p53-dependent apoptosis and leads to the spontaneous deletion of stem cells
    Trevor Hay, Teresa Patrick, Douglas J. Winton, Owen James Sansom, Alan Richard Clarke · 2005 · Oncogene
70. The Fanconi Anemia/BRCA Pathway
    Massimo Bogliolo, Jordi Surrallés · 2006 · Springer eBooks
71. Individual Radiosensitivity Does not Correlate with Radiation-Induced Apoptosis in Lymphoblastoid Cell Lines or CD3+ Lymphocytes
    Anja Wistop, Ulrike Keller, Carl N. Sprung, Gerhard G. Grabenbauer, Rolf Sauer, Luitpold Valentin Distel · 2005 · Strahlentherapie und Onkologie
72. The Caenorhabditis elegans FancD2 ortholog is required for survival following DNA damage
    Florence Dequen, Jean-François St-Laurent, Steve Gagnon, Madeleine Carreau, Serge Desnoyers · 2005 · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology
73. Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts
    Federica Guffanti, Maddalena Fratelli, Monica Ganzinelli, Marco Bolis, Francesca Ricci, Francesca Bizzaro, Rosaria Chilà, Federica Paola Sina, Robert Fruscio, Michela Lupia et al. · 2018 · Oncotarget
74. DNA repair systems in malignant mesothelioma
    Dimitrios Toumpanakis, Stamatios E Theocharis · 2011 · Cancer Letters
75. Aging, hematopoiesis, and the myelodysplastic syndromes
    Stephen S. Chung, Christopher Y. Park · 2017 · Hematology
76. Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven
    Yutian Wang, Timothy D. Wiltshire, Jamie Senft, Sharon L. Wenger, Eddie Reed, Weixin Wang · 2006 · Molecular Cancer Therapeutics
77. Disrupted Signaling through the Fanconi Anemia Pathway Leads to Dysfunctional Hematopoietic Stem Cell Biology: Underlying Mechanisms and Potential Therapeutic Strategies
    Anja Geiselhart, Amelie Lier, Dagmar Walter, Michael D. Milsom · 2012 · Anemia
78. GLI1-targeting drugs induce replication stress and homologous recombination deficiency and synergize with PARP-targeted therapies in triple negative breast cancer cells
    Chinnadurai Mani, Kaushlendra K. Tripathi, Tasmin Rahman Omy, Mark B. Reedy, Upender Manne, Komaraiah Palle · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
79. A seven‐gene signature can predict distant recurrence in patients with triple‐negative breast cancers who receive adjuvant chemotherapy following surgery
    Yeon Hee Park, Hae Hyun Jung, In‐Gu Do, Eun Yoon Cho, Insuk Sohn, Sin‐Ho Jung, Won Ho Kil, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam et al. · 2014 · International Journal of Cancer
80. A novel duplication polymorphism in the FANCApromoter and its association with breast and ovarian cancer
    Ella R. Thompson, Rebecca Dragovic, Sally‐Anne Stephenson, Diana Eccles, Ian Campbell, Alexander Dobrovic · 2005 · BMC Cancer
81. Syndromes with genetic instability: Model diseases for (skin) cancerogenesis
    Steffen Emmert, Diana Leibeling, Thomas M. Rünger · 2006 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
82. A Simplified Approach to Improve the Efficiency and Safety of Ex Vivo Hematopoietic Gene Therapy in Fanconi Anemia Patients
    Ariana Jacome, Susana Navarro, José Antonio Casado, Paula Rı́o, Luís Madero, Jesús Estella, Julián Sevilla, Isabel Badell, JUAN F MARTINEZ ORTEGA, T. Olivé et al. · 2006 · Human Gene Therapy
83. Homologous Recombination Deficiency in Ovarian and Breast Cancers: Biomarkers, Diagnosis, and Treatment
    Bhaumik Arvindkumar Shah, Muhammad Shakhawat Hussain, Anjali Seth · 2025 · Current Issues in Molecular Biology
84. A Narrative Review on Fanconi Anemia: Genetic and Diagnostic Considerations
    Preksha Sharma, Neha Sharma, Dhruva Sharma · 2022 · Global Medical Genetics
85. FancJ/Brip1 helicase protects against genomic losses and gains in vertebrate cells
    Hiroyuki Kitao, Indrajit Nanda, Ryuichi P. Sugino, Aiko Kinomura, Mitsuyoshi Yamazoe, Hiroshi Arakawa, Michael Schmid, Hideki Innan, Kevin J. Hiom, Minoru Takata · 2011 · Genes to Cells
86. DNA polymerase ι compensates for Fanconi anemia pathway deficiency by countering DNA replication stress
    Rui Wang, W. Frank Lenoir, Chao Wang, Dan Su, Megan E. McLaughlin, Qianghua Hu, Xi Hua Shen, Yanyan Tian, Naeh L. Klages-Mundt, Erica J. Lynn et al. · 2020 · Proceedings of the National Academy of Sciences
87. FANCA Gene Mutations with 8 Novel Molecular Changes in Indian Fanconi Anemia Patients
    Avani Solanki, Purvi Mohanty, Pallavi Shukla, Anita Rao, Kanjaksha Ghosh, Babu Rao Vundinti · 2016 · PLoS ONE
88. Breast cancer genetics: Unsolved questions and open perspectives in an expanding clinical practice
    Shirley Victoria Hodgson, Patrick J. Morrison, Melita D. Irving · 2004 · American Journal of Medical Genetics Part C Seminars in Medical Genetics
89. Cytogenetic sensitivity of G0 lymphocytes of Fanconi anemia patients and obligate carriers to mitomycin C and ionizing radiation
    Anahita Mohseni Meybodi, Hossein Mozdarani, P. Vosough · 2007 · Cytogenetic and Genome Research
90. Germline BRCA2 mutations detected in pediatric sequencing studies impact parents’ evaluation and care
    Michael Francis Walsh, Jennifer A. Kennedy, Megan Harlan, Alex Kentsis, Neerav Narendra Shukla, Jacob Musinsky, Stephen S. Roberts, Andrew L. Kung, Mark E. Robson, Brian H. Kushner et al. · 2017 · Molecular Case Studies
91. The Fanconi anemia pathway: Insights from somatic cell genetics using DT40 cell line
    Minoru Takata, Masamichi Ishiai, Hiroyuki Kitao · 2009 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
92. Detection and evaluation of estrogen DNA‐adducts and their carcinogenic effects in cultured human cells using biotinylated estradiol
    Kaushlendra K. Tripathi, Chinnadurai Mani, Ranganatha R. Somasagara, David W. Clark, Venkateshwari Ananthapur, Kambappa Vinaya, Komaraiah Palle · 2016 · Molecular Carcinogenesis
93. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer
    Eike Gallmeier, Tomáš Hucl, Eric S. Calhoun, Steven Clark Cunningham, Fred Bunz, Jonathan Robert Brody, Scott E. Kern · 2007 · Cancer Biology & Therapy
94. Uncoupling of transcription and translation of Fanconi anemia (FANC) complex proteins during spermatogenesis
    Duangporn Jamsai, Anne E. O’Connor, Liza O’Donnell, Jennifer Chi Yi Lo, Moira K. O’Bryan · 2014 · Spermatogenesis
95. Promise and challenges of human iPSC-based hematologic disease modeling and treatment
    Zhaohui Ye, Bin-Kuan Chou, Linzhao Cheng · 2012 · International Journal of Hematology
96. Identification of a robust DNA methylation signature for Fanconi anemia.
    D. Pagliara, A. Ciolfi, L. Pedace, S. Haghshenas, Marco Ferilli, M. Levy, E. Miele, C. Nardini, Camilla Cappelletti, R. Relator et al. · 2023 · American Journal of Human Genetics
97. Modulation of ATM enhances DNA repair in G2/M phase of cell cycle and averts senescence in Fuchs endothelial corneal dystrophy
    Shazia Ashraf, Neha R. Deshpande, Queenie Cheung, Jeffrey Boakye, Raymond K. Wong, Alex G. Gauthier, Mohit Parekh, Yadav Adhikari, Geetha Melangath, Ula V. Jurkunas · 2024 · Communications Biology
98. Dental Perspective of Rare Disease of Fanconi Anemia: Case Report with Review
    Mridula Goswami, Urvashi Bhushan, Manoj Goswami · 2016 · Clinical Medicine Insights Case Reports
99. BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies
    Weijie Poh, Robert L. Dilley, Alison R. Moliterno, Jaroslaw Pawel Maciejewski, Keith William Pratz, Michael A. McDevitt, James Gordon Herman · 2019 · Clinical Cancer Research
100. Topo IIIα and BLM Act within the Fanconi Anemia Pathway in Response to DNA-Crosslinking Agents
     Aaron Hemphill, Yassmine M. N. Akkari, Amy Hanlon Newell, Roger Alan Schultz, Markus Grompe, Phillip S. North, Ian David Hickson, Petra M. Jakobs, Scott Rennie, Daniel Pauw et al. · 2009 · Cytogenetic and Genome Research